Literature DB >> 20005678

Spread of vancomycin-resistant Enterococcus faecium in two haematological centres in Russia.

Anna N Brilliantova1, Galina A Kliasova, Anastasia V Mironova, Vladimir I Tishkov, Galina A Novichkova, Vlasta O Bobrynina, Sergei V Sidorenko.   

Abstract

This paper describes the clonal diversity of vancomycin-resistant Enterococcus faecium isolated from patients with haematological malignancies in Russia. Pulsed-field gel electrophoresis (PFGE) typing of 129 vanA-positive E. faecium strains revealed 23 independent restriction profiles with two predominant clonal types. Multilocus sequence typing (MLST) of 16 strains selected from two predominant PFGE types showed that they belong to the epidemic clonal complex (CC) 17. Tn1546-like elements of isolates were compared with the prototype element from E. faecium BM4147 by polymerase chain reaction (PCR). Four different Tn1546 types were distinguished according to structural alternations. Polymorphism in the orf1 and vanSH genes was detected. However, a significant prevalence of the prototype Tn1546 was revealed. Tn1546-like elements with the same structures were observed in strains of different PFGE types. The virulence genes esp, gelE and hyl were detected by PCR in 118 isolates (91%), 87 isolates (67%) and 35 isolates (27%), respectively. In contrast, agg and cylA genes were not found. The detection frequency of esp was higher in epidemic strains than in sporadic ones (100% vs. 56%; P<0.05). This study describes a genetically variable population of vancomycin-resistant E. faecium in two Russian haematological centres. The spread of vancomycin resistance was mostly due to the distribution of the two subclones of E. faecium CC17, enriched with the virulence marker esp. At the same time, dissemination of an altered Tn1546 also occurred. Copyright 2009 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20005678     DOI: 10.1016/j.ijantimicag.2009.10.006

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  6 in total

1.  Molecular epidemiology of vancomycin-resistant enterococci isolated from non-tertiary-care and tertiary-care hospitals in Korea.

Authors:  M K Jung; S H Ahn; W G Lee; E H Lee
Journal:  Epidemiol Infect       Date:  2014-11       Impact factor: 4.434

2.  Hospital and community ampicillin-resistant Enterococcus faecium are evolutionarily closely linked but have diversified through niche adaptation.

Authors:  Marieke J A de Regt; Willem van Schaik; Miranda van Luit-Asbroek; Huberta A T Dekker; Engeline van Duijkeren; Catherina J M Koning; Marc J M Bonten; Rob J L Willems
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

3.  Presence of virulence factors in Enterococcus faecalis and Enterococcus faecium susceptible and resistant to vancomycin.

Authors:  Carolina Baldisserotto Comerlato; Mariah Costa Carvalho de Resende; Juliana Caierão; Pedro Alves d'Azevedo
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-08       Impact factor: 2.743

4.  Genetic characteristics of VanA-type vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in Cuba.

Authors:  D Quiñones; M S Aung; J P Sousa Martins; N Urushibara; N Kobayashi
Journal:  New Microbes New Infect       Date:  2017-12-08

5.  Virulence Determinants and Antimicrobial Resistance Patterns of Vancomycin-resistant Enterococcus faecium Isolated from Different Sources in Southwest Iran.

Authors:  Maniya Arshadi; Mahmood Mahmoudi; Moloud Sadat Motahar; Saber Soltani; Mohammad Reza Pourmand
Journal:  Iran J Public Health       Date:  2018-02       Impact factor: 1.429

Review 6.  Enterococcus faecium: from microbiological insights to practical recommendations for infection control and diagnostics.

Authors:  Xuewei Zhou; Rob J L Willems; Alexander W Friedrich; John W A Rossen; Erik Bathoorn
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-10       Impact factor: 4.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.